Becton Dickinson Infusion Therapy Systems, Inc. recalls REF: 382633, BD Insyte Autoguard BC Winged, Shielded IV Catheter with Blood Control Technology, 20GA x 1.00 in (1.1x25…
- Recall date
- May 21, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2000-2025
- FDA classification
- Class II
- Brand / firm
- Becton Dickinson Infusion Therapy Systems, Inc.
- Sold / distributed
- Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV and the countries of Belgium, Canada, Chile, Colombia, Guatemala,…
Why it was recalled
Due to customer complaints, there is the possibility that catheter needle may be slow to retract or fail to retract.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
REF: 382633, BD Insyte Autoguard BC Winged, Shielded IV Catheter with Blood Control Technology, 20GA x 1.00 in (1.1x25 mm) 63 mL/min, STERILEEO, RxOnly
Get recall alerts
Free email alert whenever Becton Dickinson Infusion Therapy Systems, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Becton Dickinson Infusion Therapy Systems, Inc.